INGR Ingredion Inc
Price Chart
Executive Summary
Ingredion has entered into a definitive agreement to acquire Tate & Lyle PLC for 595 pence per share in cash (total equity value ~£2.7B / $3.6B), plus up to 20 pence in permitted dividends. To finance the acquisition, Ingredion secured a $4.225B 364-day bridge loan from JPMorgan. The combined entity would generate ~$9.9B in revenue and ~$1.8B in adjusted EBITDA, with expected cost synergies of ~$130M. The transaction is expected to close in H2 2027, pending regulatory and shareholder approvals.
Key Financial Metrics
Actionable Insight
This transformative acquisition creates a scaled specialty ingredients leader with significant synergy potential. Monitor regulatory clearance timeline (antitrust conditions are material) and Ingredion's leverage trajectory post-close. The bridge loan provides financing certainty but will need to be refinanced with permanent debt or equity within 364 days. The 58.7% premium and unanimous board recommendation suggest limited competing bid risk, but the long timeline to H2 2027 close introduces execution risk.
Key Facts
- Ingredion to acquire Tate & Lyle for 595 pence per share in cash, valuing equity at ~£2.7B ($3.6B) and enterprise value at ~£3.7B ($5.0B)
- Total consideration including permitted dividends of up to 20 pence per share values equity at ~£2.8B ($3.8B)
- Offer represents a 58.7% premium to Tate & Lyle's undisturbed closing price and a 64.0% headline premium including dividends
- Ingredion secured a $4.225B 364-day bridge loan from JPMorgan to finance the cash consideration and related costs
- Combined group expected to generate ~$9.9B revenue and ~$1.8B adjusted EBITDA
- Expected run-rate net cost synergies of ~$130M, fully realized by end of 2030, with ~$175M one-time implementation costs
- Acquisition expected to be accretive to adjusted EPS by >15% in first full fiscal year post-close
- Pro forma net debt to adjusted EBITDA expected at ~3x at close, declining to ~2.5x within 18 months
- Tate & Lyle board unanimously recommends the acquisition; irrevocable undertakings received for ~17.1% of shares
- Transaction expected to close in H2 2027, subject to regulatory and shareholder approvals
Financial Impact
Ingredion acquiring Tate & Lyle for ~£2.7B ($3.6B) equity value, financed via $4.225B bridge loan. Combined entity projected at $9.9B revenue and $1.8B EBITDA with $130M cost synergies.
Risk Factors
- Material antitrust conditions require regulatory approvals; failure could cause deal to lapse
- Integration risk from combining two large global organizations with ~16,000 total employees
- Pro forma leverage of ~3x net debt/EBITDA is elevated for an investment-grade rated company
- Expected workforce reduction of ~3% of combined group may create cultural friction
- Challenging macro environment and consumer weakness could delay synergy realization
Market Snapshot
Documents Analyzed
This report is based on 2 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-041921 |
| Exhibit: exhibit10-1xrule27announ.htm | 0001628280-26-041921 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 9, 2026
11d ago
|
8-K
| $102.54 $100.81 | ▼ −1.69% | ▼ −5.12% | $97.93 (−4.50%) |
|
Jun 8, 2026
13d ago
|
Press Release
| $99.66 $101.51 | ▲ +1.86% | ▼ −0.26% | $97.93 (−1.74%) |
|
Jun 2, 2026
18d ago
|
Press Release
| $101.12 $101.64 | ▲ +0.51% | ▲ +3.48% | $97.93 (−3.15%) |
|
May 28, 2026
23d ago
|
Press Release
| $103.21 $100.90 | ▼ −2.24% | ▼ −2.19% | $97.93 (−5.12%) |
|
May 20, 2026
4w ago
|
Press Release
| $102.15 $101.44 | ▼ −0.70% | ▼ −2.54% | $97.93 (−4.13%) |
|
May 14, 2026
5w ago
|
8-K
| $102.25 $102.15 | ▼ −0.10% | ▲ +0.62% | $97.93 (−4.22%) |
|
May 5, 2026
6w ago
|
Press Release
| $107.13 $106.20 | ▲ +0.87% | ▲ +2.85% | $97.93 (+8.59%) |
|
Apr 14, 2026
9w ago
|
Press Release
| $112.70 $112.62 | ▼ −0.07% | ▼ −1.71% | $97.93 (−13.11%) |
|
Apr 8, 2026
10w ago
|
DEFA14A
| $113.56 $112.70 | ▼ −0.76% | ▼ −4.27% | $97.93 (−13.76%) |
|
Mar 18, 2026
13w ago
|
Press Release
| $109.44 $111.01 | ▲ +1.43% | ▲ +3.64% | $97.93 (−10.52%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access